You just read:

Additional Results From BioCardia's Phase III Pivotal CardiAMP Heart Failure Trial To Be Presented At Three Influential Fall Cardiovascular Congresses

News provided by

BioCardia, Inc.

Sep 05, 2018, 08:05 ET